Cargando…
Oncolytic virotherapy for metastatic breast cancer – a case report
BACKGROUND: Breast cancer is one of the most common malignancies worldwide and remains incurable after metastasis, with a 3-year overall survival rate of <40%. CASE PRESENTATION: A 40-year-old, Caucasian patient with a grade-3 estrogen receptor-, progesterone receptor-, Her2-positive breast tumor...
Autores principales: | Gesundheit, Benjamin, Muckenhuber, Alexander, Posen, Yehudit, Ellis, Ronald, Zisman, Philip David, Schmoll, Harald, Weisslein, Christine, Srinivas Raju, Jayadeepa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282946/ https://www.ncbi.nlm.nih.gov/pubmed/37350941 http://dx.doi.org/10.3389/fonc.2023.1186888 |
Ejemplares similares
-
Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
por: Gesundheit, Benjamin, et al.
Publicado: (2020) -
Biomarkers for Autism Spectrum Disorders (ASD): A Meta-analysis
por: Ansel, Ashley, et al.
Publicado: (2019) -
Monitoring the Efficacy of Oncolytic Viruses via Gene Expression
por: Ansel, Ashley, et al.
Publicado: (2017) -
Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020) -
Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)